Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2887187 | 0.84 | CHRNB2 (0.50) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 | |
| SCHEMBL1165139 | 0.77 | CYP11B1 (0.33) | — | |
| SCHEMBL1165495 | 0.77 | LMNA (0.35) | CHRNB2CHRNA4ALDH1A1CHRNA7LMNA | |
| SCHEMBL12888668 | 0.70 | CHRNB2 (0.67) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 | |
| SCHEMBL1165504 | 0.69 | — | — | |
| SCHEMBL10028665 | 0.69 | CHRNB2 (0.85) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 | |
| SCHEMBL3460939 | 0.69 | CHRNB2 (1.00) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 | |
| SCHEMBL30632262 | 0.69 | CHRNB2 (1.00) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 | |
| SCHEMBL6583746 | 0.67 | KDM4E (0.78) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 | |
| SCHEMBL22928701 | 0.67 | CHRNB2 (0.75) | CHRNB2CHRNA4ALDH1A1KDM4ECHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2262798-B1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER IP GMBH (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-2262798-B1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER IP GMBH (DE) | 2016-06-08 | — | — | EP | disclosed |
| US-8563584-B2 | Substituted enaminothiocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2013-10-22 | — | — | US | disclosed |
| US-8563584-B2 | Substituted enaminothiocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2013-10-22 | — | — | US | disclosed |
| US-8563584-B2 | Substituted enaminothiocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2013-10-22 | — | — | US | disclosed |
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | disclosed |
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | disclosed |
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | disclosed |
| WO-2009121507-A2 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-10-08 | — | — | WO | disclosed |
| EP-2107058-A1 | Substituted enaminothiocarbonyl compounds | Bayer CropScience AG (DE) | 2009-10-07 | — | — | EP | disclosed |
| EP-2107058-A1 | Substituted enaminothiocarbonyl compounds | Bayer CropScience AG (DE) | 2009-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | DDT, PTMS, AADAC | CHRNB2 3996/4885CHRNA4 4106/4885ALDH1A1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.